Ishita Drugs & Industries Ltd

Know More
NSEBSE
Stock not tradded

75.85-0.15 (-0.20%)

10:07 AM,28th Feb 2024

BSE : 524400

NSE :

Sector : Health care

ISIN Code : INE806D01016

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 28 2024 | 10:07 AM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients drug intermediates fine chemicals and excipient. It has a state-of-art manufacturing facility in terms of reaction capabilities quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates Active Pharma Ingredients (APIs) excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).Thereafter the Company set up a project to manufacture bulk drugs at Sanand in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.'95. It established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin which was implemented in the plant during Oct.'95.The Company in 2009 undertook a small expansion cum-debottlenecking project; it upgraded many existing equipments.

Ishita Drugs & Industries Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

22

EPS - TTM (₹) [S]

2.16

P/E Ratio (X) [S]

2.38

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]31.84
P/B Ratio (₹) [S]2.38
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

75.85

76.02

Week Low/High

73.62

84.00

Month Low/High

65.92

98.00

Year Low/High

41.10

98.00

All time Low/High

0.10

98.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-5.36%%0.790.63%
1 Month6.56%%3.533.94%
3 Month2.22%%10.6111.59%
6 Month9.93%%12.6114.96%
1 Year48.87%%24.1428.26%
3 Year149.51%%49.0752.76%

Company Info

Company Information

Managing Director : Jagdish Agrawal

Director : Govind Gupta

Non Executive Director : Abha Agrawal

Director : Niranjan Agrawal

Director : Arvind Sapkal

Company Sec. & Compli. Officer : Srushti Pandya

Registered Office: Survey No 179/1 Taluka Sanand, Village Vasna-Iyava,Ahmedabad,Gujarat-382170 Ph:

Email:ishitadrugs@vsnl.net

URL:http://www.ishitadrugs.com